ARTICLE
|
doi:10.20944/preprints202309.0417.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
adenylosuccinic acid; Duchenne muscular dystrophy; myopathy; metabolic disease; skeletal muscle; toxicology; drug development
Online: 7 September 2023 (05:09:43 CEST)